First clinical case of boron neutron capture therapy for head and neck malignancies using 18F‐BPA PET

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Head and Neck

• Publication date

  2006-09-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1002/hed.20418PMID 16721735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial malignancies of the salivary glands: clinical experience of a single institution-a review.

  2004cited by this paper
• Effectiveness of BNCT for recurrent head and neck malignancies.

  2004cited by this paper
• A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease

  2003cited by this paper
• Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor

  2003cited by this paper
• Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy.

  2002cited by this paper
• Biodistribution of Boron Concentration on Melanoma‐bearing Hamsters after Administration of p‐, m‐, o‐Boronophenylalanine

  2000cited by this paper
• SERA -- An advanced treatment planning system for neutron therapy and BNCT

  1999cited by this paper
• Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.

  1998cited by this paper
• Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.

  1998cited by this paper
• Advances in the Control of Human Cutaneous Primary and Metastatic Melanoma by Thermal Neutron Capture Therapy

  1992cited by this paper
• 4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography.

  1991cited by this paper
• The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster.

  1991cited by this paper
• Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies.

  1991cited by this paper
• Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma.

  1990cited by this paper
• Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound.

  1989cited by this paper
• New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial.

  1989influential reference
• Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides.

  1989cited by this paper
• Fast neutron radiotherapy for inoperable salivary gland tumors: is it the treatment of choice?

  1987cited by this paper
• Recent advances in radiotherapy.

  1977cited by this paper

• Boron Neutron Capture Therapy: A Technology-Driven Renaissance

  2026cites this paper
• New Approaches in Radiotherapy

  2025cites this paper
• Modern Approaches to Boron-Phenylalanine Quantification in Patient Tissues for Boron Neutron Capture Therapy

  2025cites this paper
• Sensitization for proton beam therapy using 10B enriched and natural isotopic abundance of boronophenylalanine

  2025influential citation
• Advances in Clinical Trials of Boron Neutron Capture Therapy

  2025cites this paper
• Neutron capture-enhanced proton beam therapy outside the irradiation field: in vitro experiments

  2025cites this paper
• Study of dose component discrimination method using micelle gel dosimeters for quality assurance in boron neutron capture therapy.

  2025cites this paper
• Boron Nanocomposites for Boron Neutron Capture Therapy and in Biomedicine: Evolvement and Challenges

  2025cites this paper
• First Experiences of Pilot Clinical Studies on Boron Neutron Capture Therapy for Recurrent Gastrointestinal Cancers Using an Intravenous Injection of 10BPA

  2025cites this paper
• Ultrasound Combination to Improve the Efficacy of Current Boron Neutron Capture Therapy for Head and Neck Cancer

  2024cites this paper
• Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan: Real‐world experiences over a 2‐year period

  2024cites this paper
• Effects of neutron sources and moderator materials on therapeutic dose delivery to deep-seated lesions in proton accelerator-based boron neutron capture therapy.

  2024cites this paper
• Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate Derivatives

  2024cites this paper
• Preliminary study of a compact epithermal neutron absolute flux intensity measurement system for real-time in-vivo dose monitoring in boron neutron capture therapy

  2024cites this paper
• Efficacy and safety of Boron Neutron Capture Therapy: a systematic review

  2024cites this paper
• Use of a neural network-based prediction method to calculate the therapeutic dose in boron neutron capture therapy of patients with glioblastoma.

  2023cites this paper
• Boron Neutron Capture Therapy Followed by Image-Guided Intensity-Modulated Radiotherapy for Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial

  2023cites this paper
• Measurement of the applicability of various experimental materials in a medically relevant reactor neutron source Part One: Material characteristics acting as a carrier for boron compounds during neutron irradiation

  2023cites this paper
• Diagnostic and Theranostic Technologies Used in Boron Neutron Capture Therapy -A Brief Review

  2023cites this paper
• Combined BNCT-CIRT treatment planning for glioblastoma using the effect-based optimization

  2023cites this paper
• Measurement of an evaporation coefficient in tissue sections as a correction factor for 10B determination

  2023cites this paper
• Comprehensive evaluation of dosimetric impact against position errors in accelerator‐based BNCT under different treatment parameter settings

  2022cites this paper
• One step synthesis of 10B-enriched 10BPO4 nanoparticles for effective boron neutron capture therapeutic treatment of recurrent head-and-neck tumor.

  2022cites this paper
• Boron neutron capture therapy: History and recent advances

  2022cites this paper
• Synthesis and Evaluation of 18F-Labeled Boramino Acids as Potential New Positron Emission Tomography Agents for Cancer Management.

  2022cites this paper
• The Development of Boron Analysis and Imaging in Boron Neutron Capture Therapy (BNCT).

  2022cites this paper
• Dosimetric effect of set-up error in accelerator-based boron neutron capture therapy for head and neck cancer

  2022cites this paper
• Determining a methodology of dosimetric quality assurance for commercially available accelerator-based boron neutron capture therapy system

  2022cites this paper
• Theranostics in Boron Neutron Capture Therapy

  2021influential citation
• Development of a dose distribution shifter to fit inside the collimator of a Boron Neutron Capture Therapy irradiation system to treat superficial tumours.

  2021cites this paper
• Boron Neutron Capture Therapy: A Review of Clinical Applications

  2021cites this paper
• An Illustrative Example of Microdosimetry—Boron Neutron Capture Therapy for Cancer

  2021cites this paper
• Boron Neutron Capture Therapy: a New View on the Cancer Treatment

  2021cites this paper
• Analysis of influencing factors on the method for determining boron concentration and dose through dual prompt gamma detection

  2021cites this paper
• A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond

  2021cites this paper
• Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with 10B-Borocaptate Sodium (BSH) and 10B-Paraboronophenylalanine (BPA)

  2021cites this paper
• Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using 10B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results

  2021cites this paper
• Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy

  2021cites this paper
• The basis and advances in clinical application of boron neutron capture therapy

  2021cites this paper
• Comparison of Conventional and Radiomic Features between 18F-FBPA PET/CT and PET/MR

  2021cites this paper
• Combined BNCT and PET for theranostics

  2021cites this paper
• Radionuclide-labeled boron delivery agents

  2021cites this paper
• The possibility of an appropriate neutron beam achievement for medical purposes based on GEANT4 calculations

  2020cites this paper
• Boron neutron capture therapy for malignant brain tumors

  2020cites this paper
• A Case of Diffuse Astrocytoma with 32-year Survival after Boron Neutron Capture Therapy

  2020cites this paper
• Boron neutron capture therapy for head and neck cancer: Relevance of nuclear-cytoplasmic volume ratio and anti-tumor effect. -A preliminary report.

  2020cites this paper
• A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.

  2019cites this paper
• Development of proton beam irradiation system for small animals using FFAG accelerator

  2019cites this paper
• Carrier proteins-based boron delivery to tumor.

  2019cites this paper
• Similar T/N ratio between 18F-FBPA diagnostic and BPA therapeutic dosages for boron neutron capture therapy in orthotropic tongue cancer model

  2019cites this paper
• Title Boron neutron capture therapy outcomes for advanced orrecurrent head and neck cancer

  2019cites this paper
• A review of the development of In-Hospital Neutron Irradiator-1 and boron neutron capture therapy clinical research on malignant melanoma

  2018cites this paper
• In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line

  2018cites this paper
• Methodological progress in the design of clinical trials for rare diseases

  2018cites this paper
• closo-Dodecaborate-conjugated human serum albumins: preparation and in vivo selective boron delivery to tumor

  2018cites this paper
• Radiolabeling Strategies for Boron Clusters

  2018cites this paper
• Dynamic changes in 18F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and malignant melanoma during boron neutron capture therapy patient selection

  2018cites this paper
• New Boronated Compounds for an Imaging-Guided Personalized Neutron Capture Therapy

  2018cites this paper
• Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease with curative responses

  2018cites this paper
• Boron delivery agents for neutron capture therapy of cancer

  2018cites this paper
• A realistic appraisal of boron neutron capture therapy as a cancer treatment modality

  2018cites this paper
• Design and synthesis of novel organometallic complexes using boronated phenylalanine derivatives as potential anticancer agents

  2018cites this paper
• Opportunistic dose amplification for proton and carbon ion therapy via capture of internally generated thermal neutrons

  2018cites this paper
• New approaches in clinical application of laser-driven ionizing radiation

  2017cites this paper
• BNCT for Head and Neck Cancer—History at Our Institution—

  2017cites this paper
• Synthesis of Borono Fluoro Deoxy D glucose as Boron carrier for Boron neutron capture therapy (BNCT)

  2017cites this paper
• Fluorine-18 labeled amino acids for tumor PET/CT imaging

  2017cites this paper
• Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-18F-fluoro-phenylalanine (FBPA) PET study

  2016cites this paper
• Evaluation of Fluoride-18-Labeled Boronophenylalanine-Positron Emission Tomography Imaging for the Assessment of Boron Neutron Capture Therapy in Patients with Recurrent Head and Neck Squamous Cell Carcinoma

  2016cites this paper
• An interaction of the functionalized closo-borates with albumins: The protein fluorescence quenching and calorimetry study

  2016cites this paper
• A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma

  2016cites this paper
• Liposomal Boron Delivery System for Neutron Capture Therapy of Cancer

  2016cites this paper
• Boron Neutron Capture Therapy for Malignant Brain Tumors

  2016cites this paper
• Fractionated Boron Neutron Capture Therapy in Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial.

  2016cites this paper
• Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.

  2016cites this paper
• Toward a clinical application of ex situ boron neutron capture therapy for lung tumors at the RA-3 reactor in Argentina.

  2015cites this paper
• Fatal carotid blowout syndrome after BNCT for head and neck cancers.

  2015cites this paper
• Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy

  2015cites this paper
• Boron Neutron Capture Therapy (BNCT)

  2014cites this paper
• Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.

  2014cites this paper
• FBPA PET in boron neutron capture therapy for cancer: prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model

  2014cites this paper
• Boron Neutron Capture Therapy (BNCT) ホウ素中性子捕捉療法

  2014cites this paper
• Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer

  2013cites this paper
• Boron and Gadolinium Neutron Capture Therapy

  2013cites this paper
• Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature.

  2013cites this paper
• Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.

  2013cites this paper
• Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas

  2013cites this paper
• [Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy].

  2013cites this paper
• Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective.

  2013cites this paper
• Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck

  2013cites this paper
• Boron neutron capture therapy (BNCT) in Finland: technological and physical prospects after 20 years of experiences.

  2013cites this paper
• Boron Analysis and Boron Imaging in BNCT

  2012cites this paper
• Application of Neutron Capture Therapy for Locally Recurrent Breast Cancer

  2012cites this paper
• Boron Compounds: New Candidates for Boron Carriers in BNCT

  2012cites this paper
• Boronated compounds for imaging guided BNCT applications.

  2012cites this paper
• Analysis and Imaging: PET

  2012cites this paper
• Basic requirements and parameter optimization for boron neutron capture therapy of extracorporeal irradiated and auto-transplanted organs.

  2012cites this paper
• Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

  2012cites this paper
• Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.

  2012cites this paper
• Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.

  2012cites this paper